Apyx Medical (APYX) risk factors
Item 1A of every Apyx Medical Corp. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors29 risks3 reworded
Equity dilution figures were updated to reflect lower option and warrant percentages as of December 31, 2025. Macroeconomic risk discussion was updated to incorporate the Federal Reserve's rate cuts in late 2024 and 2025. Consumer demand risk now highlights GLP-1 drugs as a factor affecting discretionary spending and procedure timing.
Filed Mar 10, 2026 - FY2024 10-K risk factors29 risks
Manufacturing is concentrated in Clearwater, Florida and Sofia, Bulgaria, exposing operations to weather and supply chain disruptions. Recurring net losses raise going concern doubts, necessitating potential capital raises or operating expenditure cuts. Commercial success heavily depends on demand for elective cosmetic procedures utilizing the Renuvion and AYON technologies.
Filed Mar 13, 2025